Skip to main content
[Preprint]. 2023 Mar 31:2023.03.30.23287923. [Version 1] doi: 10.1101/2023.03.30.23287923

Figure 4. Differential decay of SARS-CoV-2-specific neutralizing antibody responses among Long COVID Symptom Phenotypes.

Figure 4.

Longitudinal decay of antibody responses compared between participants with Long COVID Symptom Phenotype (e.g. musculoskeletal, gastrointestinal, cardiopulmonary, neurocognitive) a) versus those without Long COVID (left panels) or b) versus those with other Long COVID Symptom Phenotypes (right panels). Each panel includes p-values for: the decay across all participants (“change over time”), differences in antibody neutralization for those with Long COVID phenotype across all timepoints (Symptom Phenotype), and differences in change over time with a given Long COVID phenotype (Change over time by phenotype). Shaded region represents 95% confidence intervals around the median line.